Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Artiva Biotherapeutics (ARTV) EBITDA Margin (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed EBITDA Margin for 2 consecutive years, with 5603.19% as the latest value for Q1 2024.

  • Quarterly EBITDA Margin changed N/A to 5603.19% in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 26219.12% through Dec 2024, changed N/A year-over-year, with the annual reading at 26219.12% for FY2024, 2613429.0% down from the prior year.
  • EBITDA Margin for Q1 2024 was 5603.19% at Artiva Biotherapeutics, down from 508.98% in the prior quarter.
  • The five-year high for EBITDA Margin was 42.85% in Q3 2023, with the low at 5603.19% in Q1 2024.